货号:GS40680
Sugemalimab is a fully human monoclonal antibody targeting programmed death-ligand 1 (PD-L1). It binds to PD-L1 on tumor cells and immune cells, blocking its interaction with PD-1 and B7-1 (CD80) to restore T cell function. It is approved in China for the treatment of non-small cell lung cancer (NSCLC) and is being investigated in other solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物